290 related articles for article (PubMed ID: 33549557)
1. Impact of Geographic Region on the COMMANDER-HF Trial.
Ferreira JP; Cleland JGF; Lam CSP; van Veldhuisen DJ; Byra WM; La Police DA; Anker SD; Mehra MR; Leroy C; Eschwege V; Toussaint-Hacquard M; Rossignol P; Greenberg B; Zannad F
JACC Heart Fail; 2021 Mar; 9(3):201-211. PubMed ID: 33549557
[TBL] [Abstract][Full Text] [Related]
2. Natriuretic Peptide-Based Inclusion Criteria in a Heart Failure Clinical Trial: Insights From COMMANDER HF.
Cunningham JW; Ferreira JP; Deng H; Anker SD; Byra WM; Cleland JGF; Gheorghiade M; Lam CSP; La Police D; Mehra MR; Neaton JD; Spiro TE; van Veldhuisen DJ; Greenberg B; Zannad F
JACC Heart Fail; 2020 May; 8(5):359-368. PubMed ID: 32171760
[TBL] [Abstract][Full Text] [Related]
3. A comprehensive analysis of the effects of rivaroxaban on stroke or transient ischaemic attack in patients with heart failure, coronary artery disease, and sinus rhythm: the COMMANDER HF trial.
Mehra MR; Vaduganathan M; Fu M; Ferreira JP; Anker SD; Cleland JGF; Lam CSP; van Veldhuisen DJ; Byra WM; Spiro TE; Deng H; Zannad F; Greenberg B
Eur Heart J; 2019 Nov; 40(44):3593-3602. PubMed ID: 31461239
[TBL] [Abstract][Full Text] [Related]
4. Global Prospective Safety Analysis of Rivaroxaban.
Kirchhof P; Radaideh G; Kim YH; Lanas F; Haas S; Amarenco P; Turpie AGG; Bach M; Lambelet M; Hess S; Camm AJ;
J Am Coll Cardiol; 2018 Jul; 72(2):141-153. PubMed ID: 29976287
[TBL] [Abstract][Full Text] [Related]
5. Association of Rivaroxaban With Thromboembolic Events in Patients With Heart Failure, Coronary Disease, and Sinus Rhythm: A Post Hoc Analysis of the COMMANDER HF Trial.
Greenberg B; Neaton JD; Anker SD; Byra WM; Cleland JGF; Deng H; Fu M; La Police DA; Lam CSP; Mehra MR; Nessel CC; Spiro TE; van Veldhuisen DJ; Vanden Boom CM; Zannad F
JAMA Cardiol; 2019 Jun; 4(6):515-523. PubMed ID: 31017637
[TBL] [Abstract][Full Text] [Related]
6. International variation in characteristics and clinical outcomes of patients with type 2 diabetes and heart failure: Insights from TECOS.
Bhatt AS; Luo N; Solomon N; Pagidipati NJ; Ambrosio G; Green JB; McGuire DK; Standl E; Cornel JH; Halvorsen S; Lopes RD; White HD; Holman RR; Peterson ED; Mentz RJ;
Am Heart J; 2019 Dec; 218():57-65. PubMed ID: 31707329
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular effects of rivaroxaban in heart failure patients with sinus rhythm and coronary disease with and without diabetes: a retrospective international cohort study from COMMANDER-HF.
Sharma A; Caldeira D; Razaghizad A; Pinto FJ; van Veldhuisen DJ; Mehra MR; Lam CSP; Cleland J; Anker SD; Greenberg B; Ferreira JP; Zannad F
BMJ Open; 2023 Aug; 13(8):e068865. PubMed ID: 37567750
[TBL] [Abstract][Full Text] [Related]
8. Global variation in quality of care among patients hospitalized with acute heart failure in an international trial: findings from the acute study clinical effectiveness of nesiritide in decompensated heart failure trial (ASCEND-HF).
Howlett JG; Ezekowitz JA; Podder M; Hernandez AF; Diaz R; Dickstein K; Dunlap ME; Corbalán R; Armstrong PW; Starling RC; O'Connor CM; Califf RM; Fonarow GC;
Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):534-42. PubMed ID: 23899930
[TBL] [Abstract][Full Text] [Related]
9. Heart failure with reduced ejection fraction: comparison of patient characteristics and clinical outcomes within Asia and between Asia, Europe and the Americas.
Dewan P; Jhund PS; Shen L; Petrie MC; Abraham WT; Atif Ali M; Chen CH; Desai AS; Dickstein K; Huang J; Kiatchoosakun S; Kim KS; Køber L; Lai WT; Liao Y; Mogensen UM; Oh BH; Packer M; Rouleau JL; Shi V; Sibulo AS; Solomon SD; Sritara P; Swedberg K; Tsutsui H; Zile MR; McMurray JJV
Eur J Heart Fail; 2019 May; 21(5):577-587. PubMed ID: 30536678
[TBL] [Abstract][Full Text] [Related]
10. High Risk of Stroke in Patients With Worsening Heart Failure, Reduced Ejection Fraction, Coronary Heart Disease and Sinus Rhythm: Risk Prediction Score Analysis From the COMMANDER-HF Trial.
Monzo L; Girerd N; Ferreira JP; Lamiral Z; Anker SD; Cleland JGF; Kondo T; McMurray JJV; Lam CSP; Mehra MR; Veldhuisen DJV; Greenberg B; Zannad F
J Card Fail; 2024 Apr; 30(4):618-623. PubMed ID: 38122924
[TBL] [Abstract][Full Text] [Related]
11. Regional, age and sex differences in baseline characteristics of patients enrolled in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS).
Bethel MA; Green JB; Milton J; Tajar A; Engel SS; Califf RM; Holman RR;
Diabetes Obes Metab; 2015 Apr; 17(4):395-402. PubMed ID: 25600421
[TBL] [Abstract][Full Text] [Related]
12. XANTUS-EL: A real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation in Eastern Europe, Middle East, Africa and Latin America.
Martínez CAA; Lanas F; Radaideh G; Kharabsheh SM; Lambelet M; Viaud MAL; Ziadeh NS; Turpie AGG;
Egypt Heart J; 2018 Dec; 70(4):307-313. PubMed ID: 30591748
[TBL] [Abstract][Full Text] [Related]
13. Comparing recruitment, retention, and safety reporting among geographic regions in multinational Alzheimer's disease clinical trials.
Grill JD; Raman R; Ernstrom K; Aisen P; Dowsett SA; Chen YF; Liu-Seifert H; Hake AM; Miller DS; Doody RS; Henley DB; Cummings JL
Alzheimers Res Ther; 2015; 7(1):39. PubMed ID: 26120368
[TBL] [Abstract][Full Text] [Related]
14. Rationale and design of a randomized, double-blind, event-driven, multicentre study comparing the efficacy and safety of oral rivaroxaban with placebo for reducing the risk of death, myocardial infarction or stroke in subjects with heart failure and significant coronary artery disease following an exacerbation of heart failure: the COMMANDER HF trial.
Zannad F; Greenberg B; Cleland JG; Gheorghiade M; van Veldhuisen DJ; Mehra MR; Anker SD; Byra WM; Fu M; Mills RM
Eur J Heart Fail; 2015 Jul; 17(7):735-42. PubMed ID: 25919061
[TBL] [Abstract][Full Text] [Related]
15. Geographic differences in patients with acute myocardial infarction in the PARADISE-MI trial.
Butt JH; Claggett BL; Miao ZM; Jering KS; Sim D; van der Meer P; Ntsekhe M; Amir O; Cho MC; Carrillo-Calvillo J; Núñez JE; Cadena A; Kerkar P; Maggioni AP; Steg PG; Granger CB; Mann DL; Merkely B; Lewis EF; Solomon SD; Zhou Y; Køber L; Braunwald E; McMurray JJV; Pfeffer MA
Eur J Heart Fail; 2023 Aug; 25(8):1228-1242. PubMed ID: 37042062
[TBL] [Abstract][Full Text] [Related]
16. International Variation in Outcomes Among People with Cardiovascular Disease or Cardiovascular Risk Factors and Impaired Glucose Tolerance: Insights from the NAVIGATOR Trial.
Harumi Higuchi Dos Santos M; Sharma A; Sun JL; Pieper K; McMurray JJ; Holman RR; Lopes RD
J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28087508
[TBL] [Abstract][Full Text] [Related]
17. Regional variation in clinical characteristics and outcomes in patients with atrial fibrillation: Findings from the ARISTOTLE trial.
Bahit MC; Granger CB; Alexander JH; Mulder H; Wojdyla DM; Hanna M; Goto S; Xavier D; Verheugt FWA; Lanas F; Hijazi Z; Wallentin L; Lopes RD
Int J Cardiol; 2020 Mar; 302():53-58. PubMed ID: 31932116
[TBL] [Abstract][Full Text] [Related]
18. XALIA-LEA: An observational study of venous thromboembolism treatment with rivaroxaban and standard anticoagulation in the Asia-Pacific, Eastern Europe, the Middle East, Africa and Latin America.
Kreutz R; Mantovani LG; Haas S; Monje D; Schneider J; Bugge JP; Gebel M; Tamm M; Ageno W; Turpie AGG
Thromb Res; 2019 Apr; 176():125-132. PubMed ID: 30825694
[TBL] [Abstract][Full Text] [Related]
19. XANTUS: rationale and design of a noninterventional study of rivaroxaban for the prevention of stroke in patients with atrial fibrillation.
Camm AJ; Amarenco P; Haas S; Hess S; Kirchhof P; van Eickels M; Turpie AG
Vasc Health Risk Manag; 2014; 10():425-34. PubMed ID: 25083135
[TBL] [Abstract][Full Text] [Related]
20. Insights into globalization: comparison of patient characteristics and disease progression among geographic regions in a multinational Alzheimer's disease clinical program.
Cummings JL; Atri A; Ballard C; Boneva N; Frölich L; Molinuevo JL; Raket LL; Tariot PN
Alzheimers Res Ther; 2018 Nov; 10(1):116. PubMed ID: 30474567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
